|
⚲
|
| Keyboard |
| Melrose Glenn R
✚
|
|
|---|---|
| CIK # | 0001332933 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001332933] | |
| 4 | [0001332933] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NPS Pharmaceuticals Inc | |
| Melrose Glenn R |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NPS Pharmaceuticals Inc NPSP
Common Stock
|
2014-02-13 | Tax withheld | 2,165 | $38.30 | 82,920 |
|
NPS Pharmaceuticals Inc NPSP
Common Stock
|
2014-02-13 | Option exercise | 6,075 | ||
|
NPS Pharmaceuticals Inc NPSP
Restricted Stock Units · derivative
|
2014-02-13 | Option exercise | 6,075 | $0.00 | |
|
NPS Pharmaceuticals Inc NPSP
Common Stock
|
2013-09-17 | Other | 4,539 | ||
|
NPS Pharmaceuticals Inc NPSP
Common Stock
|
2013-09-17 | Tax withheld | 1,559 | $28.36 | 44,213 |
|
NPS Pharmaceuticals Inc NPSP
Employee Stock Options (right to buy) · derivative
|
2013-02-13 | Grant | 49,005 | $0.00 | |
|
NPS Pharmaceuticals Inc NPSP
Restricted Stock Units · derivative
|
2013-02-13 | Grant | 18,226 | $0.00 | |
|
NPS Pharmaceuticals Inc NPSP
Common Stock
|
2012-11-15 | Buy | 11,000 | $9.09 | 99,990 |
|
NPS Pharmaceuticals Inc NPSP
Restricted Stock Unit
|
2012-09-17 | Grant | 13,620 | $0.00 | |
|
NPS Pharmaceuticals Inc NPSP
Common Stock · derivative
|
2012-09-17 | Grant | 22,819 | $4.93 | 112,498 |